![]() |
|
|
Vol. 303, Issue 1, 257-264, October 2002
Department of Pharmacology (L.M.S., M.I.B., X.Z., S.B.S.) and
Graduate Program in Neuroscience (S.B.S.), University of Minnesota,
Minneapolis, Minnesota
Opiate withdrawal during pregnancy may occur because of voluntary
or forced detoxification, or from rapid cycling associated with
exposure to short-acting "street" opiates. Thus, animal modeling of
prenatal withdrawal and development of potential therapeutic interventions is important. Direct developmental effects of opiates and/or withdrawal can be studied using a chick model. In ovo
administration of the long-acting opiate
N-desmethyl-l-
-noracetylmethadol
(NLAAM) induces opiate dependence in the chick embryo. We examined
activation of the hypothalamic-pituitary-adrenal (HPA) axis (assessed
via serum corticosterone) and hemodynamic changes (assessed as changes in apparent diameter of vitelline (extraembryonic) blood vessels) after
chronic NLAAM exposure and naloxone (Nx)-precipitated withdrawal during
late stages of embryogenesis. Nx-precipitated withdrawal increased
corticosterone 2- to 4.5-fold and diameters of vitelline blood vessels
by 15 to 45%. NLAAM exposure itself did not effect these measures. In
a second set of experiments, isobutylmethylxanthine (IBMX), a
phosphodiesterase inhibitor, was injected into eggs with embryos. IBMX
similarly increased corticosterone and vitelline vessel diameter, with
a similar time course and response magnitude. Previous studies found
that serotonin2 (5-HT2) receptors were involved
in other withdrawal manifestations, so we determined whether they were
likewise involved. Pretreatment with the 5-HT2 antagonist
ritanserin completely blocked HPA axis activation and vasodilation
associated with both Nx-precipitated withdrawal and IBMX
administration. This indicates that 5-HT2 receptors,
directly or indirectly, mediate these withdrawal manifestations in the chick embryo.